Assessment of SARS-CoV-2 Genome Sequencing: Quality Criteria and Low-Frequency Variants.

Détails

Ressource 1Télécharger: JCM.00944-21.pdf (946.96 [Ko])
Etat: Public
Version: de l'auteur⸱e
Licence: CC BY 4.0
ID Serval
serval:BIB_6FED6E6FD3E3
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Assessment of SARS-CoV-2 Genome Sequencing: Quality Criteria and Low-Frequency Variants.
Périodique
Journal of clinical microbiology
Auteur⸱e⸱s
Jacot D., Pillonel T., Greub G., Bertelli C.
ISSN
1098-660X (Electronic)
ISSN-L
0095-1137
Statut éditorial
Publié
Date de publication
20/09/2021
Peer-reviewed
Oui
Volume
59
Numéro
10
Pages
e0094421
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Although many laboratories worldwide have developed their sequencing capacities in response to the need for SARS-CoV-2 genome-based surveillance of variants, only a few reported some quality criteria to ensure sequence quality before lineage assignment and submission to public databases. Hence, we aimed here to provide simple quality control criteria for SARS-CoV-2 sequencing to prevent erroneous interpretation of low-quality or contaminated data. We retrospectively investigated 647 SARS-CoV-2 genomes obtained over 10 tiled amplicons sequencing runs. We extracted 26 potentially relevant metrics covering the entire workflow from sample selection to bioinformatics analysis. Based on data distribution, critical values were established for 11 selected metrics to prompt further quality investigations for problematic samples, in particular those with a low viral RNA quantity. Low-frequency variants (<70% of supporting reads) can result from PCR amplification errors, sample cross contaminations, or presence of distinct SARS-CoV2 genomes in the sample sequenced. The number and the prevalence of low-frequency variants can be used as a robust quality criterion to identify possible sequencing errors or contaminations. Overall, we propose 11 metrics with fixed cutoff values as a simple tool to evaluate the quality of SARS-CoV-2 genomes, among which are cycle thresholds, mean depth, proportion of genome covered at least 10×, and the number of low-frequency variants combined with mutation prevalence data.
Mots-clé
COVID-19, Genome, Viral, Humans, RNA, Viral, Retrospective Studies, SARS-CoV-2, accreditation, contamination, genome sequencing, quality assessment, variants of concern
Pubmed
Web of science
Open Access
Oui
Création de la notice
02/08/2021 10:47
Dernière modification de la notice
21/07/2022 7:10
Données d'usage